Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Nonrulemaking

Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application; Guidance for Industry

🏛 Food and Drug Administration (FDA)FDA-2026-D-4692
Documents
1
Total comments
1
all analyzed
Comment status
Open
Last activity
Jul 10, 2026
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 1Other 1
📄 Primary document
OtherMay 5, 2026
Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application; Guidance for Industry
No comment period💬 1 comment
Open →